FDA plans to ease rules for reprinting off-label use info
March 10th, 2008 Posted by: Dr. Dobson
Washington — Drug firms would have a more direct route to physicians when it comes to spreading the word about new research findings for off-label uses of drugs and devices, if a new Food and Drug Administration proposal is finalized.
The proposal, which was published in the Feb. 20 Federal Register Read the rest of this entry »
Popularity: unranked [?]
Tags: plans, rules, reprinting, off-label